Skip to main content
. 2015 May 13;10(5):e0126390. doi: 10.1371/journal.pone.0126390

Fig 2. Plots of the activities of S1, Nal2-S1, K4R2-Nal2-S1, and K6-Nal2-S1 against OECM-1, C9, SAS, A549, PC9, PC9-G cancer cell lines.

Fig 2